Comparative aspects and clinical outcomes of canine renal hemangiosarcoma

Journal of Veterinary Internal Medicine

Volumn 20, Issue 4, 2006, Pages 962-967

  Locke, Jennifer E ^a   Barber, Lisa G ^b  

^a IOWA STATE UNIVERSITY   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

Hemoperitoneum; Kidney tumor; Sarcoma; Vascular neoplasia

Indexed keywords

ANGIOSARCOMA; ANIMAL; ANIMAL DISEASE; ARTICLE; COMPARATIVE STUDY; DOG; DOG DISEASE; KIDNEY TUMOR; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

ANIMALS; DOG DISEASES; DOGS; HEMANGIOSARCOMA; KIDNEY NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

ANIMALIA; CANIS FAMILIARIS;

EID: 33748351555     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2006)20[962:CAACOO]2.0.CO;2     Document Type: Article

References (24)

1. Hammer AS, Couto CG, Filppi J, et al. Efficacy and toxicity of VAC chemotherapy (vincristine, doxorubicin, and cyclophosphamide) in dogs with hemangiosarcoma. J Vet Intern Med 1991;5:160-166.
2. Pearson GR, Head KW. Malignant haemangioendothelioma (angiosarcoma) in the dog. J Small Anim Pract 1976;17:737-745.
3. Sorenmo KU, Baez JL, Clifford CA, et al. Efficacy and toxicity of a dose-intensified doxorubicin protocol in canine hemangiosarcoma. J Vet Intern Med 2004;18:209-213.
4. Clifford CA, Mackin AJ, Henry CJ. Treatment of canine hemangiosarcoma: 2000 and beyond. J Vet Intern Med 2000; 14:479-485.
5. Ward H, Fox LE, Calderwood-Mays MB, et al. Cutaneous hemangiosarcoma in 25 dogs: A retrospective study. J Vet Intern Med 1994;8:345-348.
6. Brown NO. Hemangiosarcomas. Vet Clin North Am Small Anim Pract 1985;15:569-575.
7. Schultheiss PC. A retrospective study of visceral and nonvisceral hemangiosarcoma and hemangiomas in domestic animals. J Vet Diagn Invest 2004;16:522-526.
8. Dunning D, Monnet E, Orton EC, Salman MD. Analysis of prognostic indicators for dogs with pericardial effusion: 46 cases (1985-1996). J Am Vet Med Assoc 1998;212:1276-1280.
9. Sorenmo KU, Jeglum KA, Helfand SC. Chemotherapy of canine hemangiosarcoma with doxorubicin and cyclophosphamide. J Vet Intern Med 1993;7:370-376.
10. Wood CA, Moore AS, Gliatto JM, et al. Prognosis for dogs with stage I or II splenic hemangiosarcoma treated by splenectomy alone: 32 cases (1991-1993). J Am Anim Hosp Assoc 1998; 34:417-421.
11. Ware WA, Hopper DL. Cardiac tumors in dogs: 1982-1995. J Vet Intern Med 1999;13:95-103.
12. Weisse C, Scares N, Beal MW, et al. Survival times in dogs with right atrial hemangiosarcoma treated by means of surgical resection with or without adjuvant chemotherapy: 23 cases (1986-2000). J Am Vet Med Assoc 2005;226:575-579.
13. Johnson KA, Powers BE, Withrow SJ, et al. Splenomegaly in dogs. Predictors of neoplasia and survival after splenectomy. J Vet Intern Med 1989;3:160-166.
14. Srebernik N, Appleby EC. Breed prevalence and sites of haemangioma and haemangiosarcoma in dogs. Vet Rec 1991;129:408-409.
15. Spangler WL, Kass PH. Pathologic factors affecting postsplenectomy survival in dogs. J Vet Intern Med 1997; 11:166-171.
16. Ogilvie GK, Powers BE, Mallinckrodt CH, Withrow SJ. Surgery and doxorubicin in dogs with hemangiosarcoma. J Vet Intern Med 1996;10:379-384.
17. Smith AN. Hemangiosarcoma in dogs and cats. Vet Clin North Am Small Anim Pract 2003;33:533-552, vi.
18. Liptak JM, Dernell WS, Ehrhart EJ, et al. Retroperitoneal sarcomas in dogs: 14 cases (1992-2002). J Am Vet Med Assoc 2004;224:1471-1477.
19. Meleo KA. Tumors of the skin and associated structures. Vet Clin North Am Small Anim Pract 1997;27:73-94.
20. Limmer S, Wagner T, Leipprand E, Arnholdt H. Das primäre renale Hämangiosarkom: Fallbeschreibung und Literaturübersicht [Primary renal hemangiosarcoma. Case report and review of the literature]. Pathologe 2001;22:343-348.
21. Sorenmo K, Duda L, Barber L, et al. Canine hemangiosarcoma treated with standard chemotherapy and minocycline. J Vet Intern Med 2000;14:395-398.
22. Pintar J, Breitschwerdt EB, Hardie EM, Spaulding KA. Acute nontraumatic hemoabdomen in the dog: A retrospective analysis of 39 cases (1987-2001). J Am Anim Hosp Assoc 2003;39:518-522.
23. Vail DM, MacEwen EG, Kurzman ID, et al. Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: A randomized multi-institutional clinical trial. Clin Cancer Res 1995;1:1165-1170.
24. MacEwen EG, Kurzman ID, Helfand S, et al. Current studies of liposome muramyl tripeptide (CGP 19835A lipid) therapy for metastasis in spontaneous tumors: A progress review. J Drug Target 1994;2:391-396.